Pirtobrutinib(loxo-305) Interesting study - CLL Support

CLL Support

22,514 members38,671 posts

Pirtobrutinib(loxo-305) Interesting study

Varney profile image
15 Replies

Hi All,

If you haven’t seen it, here is a interesting study done at the James Center at Ohio State University. Dr. Woyach co-led the study and is also heading up the clinical trial that I have been in since 2019 (I/O; V/I/O).

cancer.osu.edu/news/woyach-...

Varney

Written by
Varney profile image
Varney
To view profiles and participate in discussions please or .
Read more about...
15 Replies
ironjohn profile image
ironjohn

Thank you for the link, this is great news.

Best wishes

John

Varney profile image
Varney in reply to ironjohn

Best to you

Varney

Thundercat2 profile image
Thundercat2

This is good news Varney. Thank you for posting!

Varney profile image
Varney in reply to Thundercat2

You are welcome. Hope this finds you doing well.

Varney

annmcgowan profile image
annmcgowan

Thank you, excellent news.

Ann

Varney profile image
Varney in reply to annmcgowan

You are welcome. Take care

Nicebaps profile image
Nicebaps

Hi Varney

I'm from the UK and aged 61. I've been on Pirtobrutinib since October 2022. I've had very few side effects and the ones I have had have been negligible. For me, response time was very slow in clearing the disease in my Bone Marrow. Pirtobrutinib is not yet approved in the UK so got mine for compassionate use.

Hopefully it will soon become available for all CLL patients, fingers crossed.

Varney profile image
Varney in reply to Nicebaps

Thanks for your comments. It takes a little longer on the single drug therapy “ibs” to lower the absolute lymphocyte count, but you will get there. Glad the side effects are minimal. That is huge. I hope Pirtobrutinib is approved everywhere for CLL. Headed your way next month. Going to your neighbor next door (Ireland). Wishing you the very best on Pirtobrutinib. Take care

Varney

DaveCll profile image
DaveCll

Thanks for sharing this article. I have been on it since March with great results. In fact instead of putting me on the O my Doctor put me on this drug and then the V. So far all is good just a little neutropinia but everything else is great.

Varney profile image
Varney in reply to DaveCll

Wow! That is so great. Glad you are doing well and not having many side effects. A lot of people on this site will be happy to hear that. Wishing you the very best.

Varney

vman82 profile image
vman82

Loved reading this article - thank you for sharing Varney ! - it can only get better from here for folks like us :)

Best

Vishaal

Varney profile image
Varney in reply to vman82

Thanks

Pacificview profile image
Pacificview

Thank you for sharing that. Gives me great hope for down the road in my future treatment options. Currently half way through O & V first treatment. More future treatment options the better in my mind.John

Varney profile image
Varney in reply to Pacificview

They certainly have made great strides in last 10years from just chemo to targeted meds which are getting better and better. A bright future for those of us afflicted with this disease.

Varney

Varney profile image
Varney in reply to Pacificview

Thanks for responding. I think you are on a good treatment and hopefully your side effects have been minimal. Wishing you the very best on the rest of your journey.

Varney

You may also like...

Pirtobrutinib (formerly LOXO-305)

something really unique about this molecule early on....

BRUIN Study: phase 1/2 study of Pirtobrutinib (formerly Loxo 305) in relapsed or refractory B-cell malignancies

expected to continue until February 2023. Trial information here:...

LOXO-305 UPDATE 7 CYCLES COMPLETE

back I posted some results from my LOXO-305 clinical trial. I am now into my 8th 28 day cycle with...

Finishing line for Pirtobrutinib (Loxo) & Venetoclax combination trial.

year combination clinical trial with Pirtobrutinib and Venetoclax - I think a small study of us in...

LATEST AND GREATEST LOXO-305 UPDATE

participants for the trial . All of the study results and information has been very positive so far.